What is Sofinnova Partners?
Headquartered in Paris with a robust presence in London and Milan, Sofinnova Partners operates as a specialized venture capital firm dedicated to the life sciences industry. The firm distinguishes itself through a hands-on approach to company building, providing not only financial backing but also deep scientific, medical, and business expertise. Their investment strategy spans the entire lifecycle of a company, from early-stage seed rounds to mature, later-stage developments. By partnering with visionary entrepreneurs, Sofinnova Partners facilitates the transition of complex scientific breakthroughs into viable, market-ready solutions that address critical global health and sustainability challenges.
How much funding has Sofinnova Partners raised?
Sofinnova Partners has raised a total of $1B across 1 funding round:
Share Placement
$1B
Share Placement (2022): $1B with participation from Apollo Global Management
Key Investors in Sofinnova Partners
Apollo Global Management
A global alternative asset manager that provides innovative capital solutions and focuses on long-term value creation across diverse sectors.
What's next for Sofinnova Partners?
With the recent infusion of capital, Sofinnova Partners is well-positioned to accelerate its strategic initiatives in the life sciences landscape. The firm is expected to deepen its commitment to high-impact healthcare ventures, focusing on the development of next-generation therapeutics and sustainable technologies. As the firm continues to act as a lead or cornerstone investor, the focus will likely remain on scaling its portfolio companies to achieve commercial viability and long-term market influence. This strategic growth phase will likely involve expanding their footprint in key European innovation hubs, further cementing their reputation as a cornerstone of the continent's biotech and healthcare investment ecosystem.
See full Sofinnova Partners company page
